Technical Specifications Compound: Glycyl-L-Histidyl-L-Lysine Copper Complex (GHK-Cu) Format: Lyophilized peptide Strength: 50 mg per vial Purity: 9899% (COA included) Appearance: Blue-hued lyophilized powder Category: Research reagent (non-clinical) Intended Use This product is intended exclusively for: Laboratory research In-vitro experimentation Biochemical and molecular assays Mechanistic pathway studies Preclinical, non-human model exploration Institutional or academic research programs Not intended for: Human or veterinary consumption Cosmetic or dermatological use Injection, ingestion, inhalation, or topical use Medical, therapeutic, or clinical applications This material is not approved by Health Canada, FDA, or any regulatory authority for clinical use
Your prescriber may recommend a dose reduction rather than stopping entirely
As we age, our bodies make less growth hormone which can lead to troubles like weak bones or loss of muscle
Finding a knowledgeable practitioner helps ensure safe and appropriate use
The FDA's October 2024 PCAC review documents specifically noted limited clinical data on this combination
Statistical comparative study between the conventional DPPH spectrophotometric and dropping DPPH analytical method without spectrophotometer: Evaluation for the advancement of antioxidant activity analysis